Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show, Webcast

Savara to Present at the Jefferies London Healthcare Conference


Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that its management team will present at the Jefferies London Healthcare Conference being held November 16-19, 2021.

A pre-recorded, on-demand webcast of Savara's presentation will be available on the conference website beginning Thursday, November 18 at 3:00 am ET through Friday, November 19 at 12:00 pm ET. Additionally, a replay of the presentation will be available on the Investors page of Savara's website at www.savarapharma.com/investors/events-presentations/ for 90 days following the event.

About Savara

Savara is a clinical stage biopharmaceutical company focused on rare respiratory diseases. Our lead program, molgramostim nebulizer solution, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). Molgramostim is delivered via an investigational eFlow® Nebulizer System (PARI Pharma GmbH). Our management team has significant experience in rare respiratory diseases and pulmonary medicine, identifying unmet needs, and effectively advancing product candidates to approval and commercialization.

More information can be found at www.savarapharma.com. (Twitter: @SavaraPharma, LinkedIn: www.linkedin.com/company/savara-pharmaceuticals/).


These press releases may also interest you

at 01:15
Technavio categorizes the global vascular endothelial growth factor (VEGF) inhibitors market as a part of the pharmaceutical market within the overall healthcare industry. The vascular endothelial growth factor (VEGF) inhibitors market research...

at 01:05
BeiGene, Ltd. , a global biotechnology company focused on developing and commercializing innovative medicines worldwide, yesterday announced the opening of a new regional office in Basel, Switzerland. BeiGene has built a European organization,...

at 01:00
BenevolentAI (Euronext Amsterdam: BAI), a leading clinical-stage AI-enabled drug...

at 00:00
Clinical trial professionals need to harness the power within their clinical trial data. This free webinar will show them how to take control. There's no doubt the volume, variety and velocity of data has never been greater, with the number of unique...

at 00:00
Drug and device manufactures need to understand their company's culture of quality and how it might be improved. Have their efforts made to date fallen on deaf ears? Is there a way to measure what's working, and more importantly what's not, so...

16 mai 2022
In 2007, after many years in the recruiting industry and entrepreneurship in his DNA, TurningPoint's CEO & Founder, Ken Schmitt, decided it was time to change the standard for recruiting. He envisioned a high-touch, personalized approach to...



News published on 10 november 2021 at 08:20 and distributed by: